<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
    <channel>
        <title>PR.com Press Releases: Synergy Research Group News</title>
        <description>Latest news releases from PR.com for Synergy Research Group.</description>
        <link>http://www.pr.com/press-releases</link>
        <lastBuildDate>Mon, 13 Oct 2008 14:21:47 -0500</lastBuildDate>
        <image>
            <url>http://www.pr.com/images/logo_white.jpg</url>
            <title>Press Releases from PR.com</title>
            <link>http://www.pr.com/</link>
            <width>68</width>
            <height>69</height>
            <description>PR.com provides Free Press Release Distribution, &amp; is a unique Directory of Businesses, Products, Services, &amp; Jobs - in all industries.  Find Full Company Profiles.</description>
        </image>
        <copyright>© 2008 PR Worldwide, Inc.</copyright>
        <ttl>60</ttl>
        <item>
            <title>Clinical Trials in Russia. 2nd Quarter 2008</title>
            <link>http://www.pr.com/press-release/97104</link>
            <description>On July 24, 2008 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analysis of the clinical trial market in Russia. The report contains hundreds of figures as well as dozens of tables and pictures covering various aspects of the Russian clinical trial market. This is another step to formation of a civilized market of clinical trials in Russia and improvement of [PR.com - July 26, 2008]</description>
            <author>Synergy Research Group</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/97104</guid>
        </item>
        <item>
            <title>A Russian and Pakistani CRO Announce Alliance for Expansion of Global Clinical Trials Services</title>
            <link>http://www.pr.com/press-release/92931</link>
            <description>On June 30, 2008 Synergy Research Group (SynRG), a Russia-based CRO with more than 6-year experience in clinical trials in Russia announced the establishment of a new international CRO alliance with Metrics Research, a Pakistan-based CRO. This is the next step made by SynRG toward the formation of a CRO Worldwide Network capable to compete with global CROs in bids for large international multi-center clinical studies. The [PR.com - July 02, 2008]</description>
            <author>Synergy Research Group</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/92931</guid>
        </item>
        <item>
            <title>Clinical Trials in Russia. 1st Quarter 2008</title>
            <link>http://www.pr.com/press-release/88209</link>
            <description>On June 2, 2008 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analytical report on the market of clinical trials in Russia. According to the report The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (alias RosZdravNadzor, RZN) approved 130 new clinical trials in Russia in Q1 2008. [PR.com - June 04, 2008]</description>
            <author>Synergy Research Group</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/88209</guid>
        </item>
        <item>
            <title>Clinical Trials in Russia, 4th Quarter 2007</title>
            <link>http://www.pr.com/press-release/72783</link>
            <description>On February 18, 2008 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analytical report on the market of clinical trials in Russia. The report contains hundreds of figures as well as dozens of tables and pictures covering various aspects of the Russian Clinical Trials market. This is another step to formation of a civilized market of clinical trials in Russia [PR.com - February 20, 2008]</description>
            <author>Synergy Research Group</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/72783</guid>
        </item>
        <item>
            <title>Clinical Trials in Russia, 3rd Quarter 2007</title>
            <link>http://www.pr.com/press-release/60271</link>
            <description>According to SynRG Orange Paper, in the 3rd Quarter 2007, the overall volume of the clinical trials in Russia and its basic parameters are generally the same as in the corresponding quarter of the last year. In the 3rd Quarter 2007 RosZdravNadzor (RZN) has issued 141 approvals for conducting new clinical trials, which is 2% more than in Q3 2006. [PR.com - November 14, 2007]</description>
            <author>Synergy Research Group</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/60271</guid>
        </item>
        <item>
            <title>Russian and Indian CROs Announce Network Alliance for Expansion of Global Clinical Trials Services</title>
            <link>http://www.pr.com/press-release/52009</link>
            <description>On September 12, 2007 Synergy Research Group (SynRG), a Russia-based CRO with more than 5-years experience in clinical trials in Russia announced the establishment of a new CRO Worldwide Network alliance with Neeman Medical International (NMI), an India-based CRO. This is the second step made by SynRG in formation of the CRO Worldwide Network being able to compete with global CROs in the bids for large international [PR.com - September 14, 2007]</description>
            <author>Synergy Research Group</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/52009</guid>
        </item>
        <item>
            <title>Synergy Research Group and Promedica International Announce Global Network Alliance for Expansion of Global Clinical Trials Services</title>
            <link>http://www.pr.com/press-release/47515</link>
            <description>On August 2, 2007 Synergy Research Group (SynRG), a Russia based CRO with more than 5-years experience in clinical trials in Russia announced today the establishment of a new Global Network Alliance with Promedica International (PMI), a USA-based CRO.

Promedica International (PMI), which specializes in Phase II-IV clinical research, has been serving device, pharmaceutical and biotech markets for over two decades from its [PR.com - August 04, 2007]</description>
            <author>Synergy Research Group</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/47515</guid>
        </item>
        <item>
            <title>Clinical Trials in Russia - 2nd Quarter 2007</title>
            <link>http://www.pr.com/press-release/46552</link>
            <description>On July 25, 2007 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analytical report on the market of clinical trials in Russia. The report contains hundreds of figures as well as 11 Tables and 9 Pictures covering various aspects of the Russian Clinical Trials market. This is another step to formation of a civilized market of clinical trials in Russia and [PR.com - July 27, 2007]</description>
            <author>Synergy Research Group</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/46552</guid>
        </item>
        <item>
            <title>Clinical Trials in Russia. 1st Quarter 2007 Results</title>
            <link>http://www.pr.com/press-release/41028</link>
            <description>According to Synergy Research Group, a Russia-based CRO, the growth in the number of clinical trials approved by the Russian Federal Agency for Health Care and Social Development (Roszdravnadzor) made up to nearly 40% in the 1st Quarter of 2007 as compared to the same quarter of the previous year. At the same time, the share of clinical studies initiated by Russian manufacturers has increased. [PR.com - June 06, 2007]</description>
            <author>Synergy Research Group</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/41028</guid>
        </item>
        <item>
            <title>Clinical Trials in Russia - First Issue of SynRG Orange Paper</title>
            <link>http://www.pr.com/press-release/38858</link>
            <description>On April 25, 2007, the first issue of the Orange Paper &amp;ndash; the first analytical review on market of clinical trials in Russia &amp;ndash; was officially presented. The strategic goals of Synergy Research Group, a Russia-based emerging CRO, are formation of a civilized market of clinical trials in Russia, raising the country&amp;rsquo;s research attractiveness for foreign sponsors, and exoneration of clinical trials in Russian [PR.com - May 16, 2007]</description>
            <author>Synergy Research Group</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/38858</guid>
        </item>
    </channel>
</rss>
